Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egberts

Showing results (711-720 of 1,066) with videos related to

Pageof 107
Sort By:
British Journal of Clinical Pharmacology|July 30, 2008
The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepamBeitske E Smink, Berendina J A Hofman, Albert Dijkhuizen, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medicationJochem G Gregoor, Hans Mulder, Dan Cohen, et al.
Drug Safety|September 4, 2010
Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBaseThijs J Giezen, Aukje K Mantel-Teeuwisse, Ronald H B Meyboom, et al.
Archives of Internal Medicine|October 29, 2003
Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patientsKris L L Movig, Michiel W H E Janssen, Jan de Waal Malefijt, et al.
Journal of Cell Science|May 6, 2004
Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiationFriederike Egberts, Michael Heinrich, Jens-Michael Jensen, et al.
European Journal of Clinical Pharmacology|July 9, 2013
The association between CYP2D6 genotype and switching antipsychotic medication to clozapineJochem G Gregoor, Karen van der Weide, Jan van der Weide, et al.
Drug Safety|November 18, 2009
Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approvalThijs J Giezen, Aukje K Mantel-Teeuwisse, Sabine M J M Straus, et al.
BMC Health Services Research|April 25, 2019
What does it cost to redispense unused medications in the pharmacy? A micro-costing studyCharlotte L Bekker, Helga Gardarsdottir, Antoine C G Egberts, et al.
European Geriatric Medicine|May 31, 2022
Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric wardNikki M F Noorda, Bastiaan T G M Sallevelt, Wivien L Langendijk, et al.
BMC Health Services Research|February 17, 2010
The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patientsFatma Karapinar-Carkit, Sander D Borgsteede, Jan Zoer, et al.
Pageof 107

Showing results (711-720 of 1,066) with videos related to

Sort By:
Pageof 107
British Journal of Clinical Pharmacology|July 30, 2008
The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepamBeitske E Smink, Berendina J A Hofman, Albert Dijkhuizen, et al.
Journal of Clinical Psychopharmacology|November 25, 2010
Combined HTR2C-LEP genotype as a determinant of obesity in patients using antipsychotic medicationJochem G Gregoor, Hans Mulder, Dan Cohen, et al.
Drug Safety|September 4, 2010
Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBaseThijs J Giezen, Aukje K Mantel-Teeuwisse, Ronald H B Meyboom, et al.
Archives of Internal Medicine|October 29, 2003
Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patientsKris L L Movig, Michiel W H E Janssen, Jan de Waal Malefijt, et al.
Journal of Cell Science|May 6, 2004
Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiationFriederike Egberts, Michael Heinrich, Jens-Michael Jensen, et al.
European Journal of Clinical Pharmacology|July 9, 2013
The association between CYP2D6 genotype and switching antipsychotic medication to clozapineJochem G Gregoor, Karen van der Weide, Jan van der Weide, et al.
Drug Safety|November 18, 2009
Evaluation of post-authorization safety studies in the first cohort of EU Risk Management Plans at time of regulatory approvalThijs J Giezen, Aukje K Mantel-Teeuwisse, Sabine M J M Straus, et al.
BMC Health Services Research|April 25, 2019
What does it cost to redispense unused medications in the pharmacy? A micro-costing studyCharlotte L Bekker, Helga Gardarsdottir, Antoine C G Egberts, et al.
European Geriatric Medicine|May 31, 2022
Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric wardNikki M F Noorda, Bastiaan T G M Sallevelt, Wivien L Langendijk, et al.
BMC Health Services Research|February 17, 2010
The effect of the COACH program (Continuity Of Appropriate pharmacotherapy, patient Counselling and information transfer in Healthcare) on readmission rates in a multicultural population of internal medicine patientsFatma Karapinar-Carkit, Sander D Borgsteede, Jan Zoer, et al.
Pageof 107